NO976094D0 - Nye peptider avledet av humant varmesjokkprotein 60 for behandling av diabetes, fremgangsmåte og sett - Google Patents

Nye peptider avledet av humant varmesjokkprotein 60 for behandling av diabetes, fremgangsmåte og sett

Info

Publication number
NO976094D0
NO976094D0 NO976094A NO976094A NO976094D0 NO 976094 D0 NO976094 D0 NO 976094D0 NO 976094 A NO976094 A NO 976094A NO 976094 A NO976094 A NO 976094A NO 976094 D0 NO976094 D0 NO 976094D0
Authority
NO
Norway
Prior art keywords
diabetes
kit
treatment
heat shock
shock protein
Prior art date
Application number
NO976094A
Other languages
English (en)
Other versions
NO320715B1 (no
NO976094L (no
Inventor
Irun R Cohen
Dana Elias
Rivka Abulafia
Jana Bockova
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO976094D0 publication Critical patent/NO976094D0/no
Publication of NO976094L publication Critical patent/NO976094L/no
Publication of NO320715B1 publication Critical patent/NO320715B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO19976094A 1995-06-30 1997-12-29 Nye peptider avledet av humant varmesjokkprotein 60, farmasoytiske preparater omfattende slike og anvendelse av de nye peptider for fremstilling av farmasoytiske preparater for behandling og forebyggelse av insulinavhengig diabetes mellitus, samt fremgangsmate og sett for diagnostisering av IDDM. NO320715B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11440795A IL114407A0 (en) 1995-06-30 1995-06-30 Novel peptides and pharmaceutical compositions comprising them
PCT/US1996/011375 WO1997001959A1 (en) 1995-06-30 1996-07-01 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits

Publications (3)

Publication Number Publication Date
NO976094D0 true NO976094D0 (no) 1997-12-29
NO976094L NO976094L (no) 1998-02-02
NO320715B1 NO320715B1 (no) 2006-01-23

Family

ID=11067704

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19976094A NO320715B1 (no) 1995-06-30 1997-12-29 Nye peptider avledet av humant varmesjokkprotein 60, farmasoytiske preparater omfattende slike og anvendelse av de nye peptider for fremstilling av farmasoytiske preparater for behandling og forebyggelse av insulinavhengig diabetes mellitus, samt fremgangsmate og sett for diagnostisering av IDDM.

Country Status (19)

Country Link
US (1) US6682897B1 (no)
EP (1) EP0845943B1 (no)
KR (1) KR100454554B1 (no)
CN (1) CN1102598C (no)
AR (1) AR003446A1 (no)
AT (1) ATE290315T1 (no)
AU (1) AU710882B2 (no)
CA (1) CA2225675C (no)
CZ (1) CZ295110B6 (no)
DE (1) DE69634438T2 (no)
DK (1) DK0845943T3 (no)
ES (1) ES2239770T3 (no)
HR (1) HRP960307A2 (no)
HU (1) HUP9901688A3 (no)
IL (2) IL114407A0 (no)
NO (1) NO320715B1 (no)
UY (1) UY24270A1 (no)
WO (1) WO1997001959A1 (no)
ZA (1) ZA965565B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
ATE249046T1 (de) * 1996-05-14 2003-09-15 Winnacker Ernst Ludwig Prof Chaperone, die prionproteine binden und zwischen den isoformen prpc und prpsc unterscheiden können
US5993803A (en) * 1996-08-30 1999-11-30 Yeda Research And Development Co., Ltd. Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
JP2004501061A (ja) * 1999-12-15 2004-01-15 ペプトル・リミテツド 熱ショックタンパク質６０のフラグメントおよびアンタゴニスト
EP1335741A4 (en) * 2000-08-25 2005-10-26 Yeda Res & Dev METHOD FOR THE PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDES (04.03.02)
WO2003063759A2 (en) 2002-01-31 2003-08-07 Peptor Ltd. Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
WO2003070761A1 (en) * 2002-02-19 2003-08-28 Yeda Research And Development Co. Ltd. Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
AU2003230181A1 (en) 2002-05-21 2003-12-02 Yeda Research And Development Co. Ltd. Dna vaccines encoding heat shock proteins
WO2004098489A2 (en) * 2003-05-12 2004-11-18 Peptor Ltd. Compositions and methods for modulation of specific epitopes of hsp60
WO2005048914A2 (en) * 2003-11-24 2005-06-02 Yeda Research & Development Co. Ltd. Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
EP1718158B1 (en) 2004-01-28 2014-07-02 Andromeda Bio Tech Ltd. Hsp therapy in conjunction with a low antigenicity diet
EP1835933A4 (en) * 2005-01-04 2015-01-07 Yeda Res & Dev HSP60, HSP60-PEPTIDES AND T-CELL VACCINES FOR IMMUNOMODULATION
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
US9102942B2 (en) 2010-02-04 2015-08-11 EWHA University—Industry Collaboration Foundation Pharmaceutical composition for inhibiting abnormal proliferation of cells
ITCO20120007A1 (it) 2012-02-21 2013-08-22 Nuovo Pignone Srl Dispositivo di filtraggio dell'aria in ingresso per un impianto
WO2013128453A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides
IN2014MN01887A (no) 2012-03-01 2015-07-10 Yeda Res & Dev
US10864253B2 (en) * 2016-04-29 2020-12-15 Araim Pharmaceuticals, Inc. Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage
CN111035755B (zh) * 2020-01-08 2023-04-14 中国医学科学院医学生物学研究所 一种1型糖尿病疫苗及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242823A (en) * 1986-03-07 1993-09-07 International Genetic Engineering, Inc. Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
CA2225675C (en) 2010-09-21
ZA965565B (en) 1997-02-26
HUP9901688A3 (en) 1999-12-28
EP0845943A4 (en) 2002-04-10
MX9800191A (es) 1998-05-31
IL122757A (en) 2001-07-24
EP0845943B1 (en) 2005-03-09
CZ295110B6 (cs) 2005-05-18
AR003446A1 (es) 1998-08-05
JPH11509196A (ja) 1999-08-17
CN1193889A (zh) 1998-09-23
CN1102598C (zh) 2003-03-05
DK0845943T3 (da) 2005-07-11
WO1997001959A1 (en) 1997-01-23
CZ411797A3 (cs) 1998-06-17
HUP9901688A2 (hu) 1999-09-28
NO320715B1 (no) 2006-01-23
US6682897B1 (en) 2004-01-27
DE69634438T2 (de) 2006-02-09
AU6484596A (en) 1997-02-05
UY24270A1 (es) 2000-12-29
NO976094L (no) 1998-02-02
IL114407A0 (en) 1995-10-31
DE69634438D1 (de) 2005-04-14
EP0845943A1 (en) 1998-06-10
KR100454554B1 (ko) 2005-04-06
ES2239770T3 (es) 2005-10-01
IL122757A0 (en) 1998-08-16
HRP960307A2 (en) 1998-04-30
JP3955627B2 (ja) 2007-08-08
CA2225675A1 (en) 1997-01-23
AU710882B2 (en) 1999-09-30
ATE290315T1 (de) 2005-03-15
KR19990028640A (ko) 1999-04-15

Similar Documents

Publication Publication Date Title
NO976094L (no) Nye peptider avledet av humant varmesjokkprotein 60 for behandling av diabetes, fremgangsmåte og sett
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
DK0833649T3 (da) Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier og fremgangsmåder til fremstilling og anvendelser deraf
ATE348113T1 (de) Rekombinanter anti-cd4 antikörper zur menschlichen behandlung
NO986089D0 (no) Metoder og preparater for behandling av tumorer, tumorrelaterte sykdommer o
IS4343A (is) Einstofna offitu (Ob) prótín
LV11615A (lv) Amidi ar arstnieciskam ipasibam
NO961006D0 (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
DE69630479D1 (de) Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten
FI952721A7 (fi) Aine maksa-sappi-sairauksien hoitamiseksi
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
NO20001869L (no) FremgangsmÕte for behandling av Alzheimers sykdom
EP1039883A4 (en) METHOD FOR TREATING APOLIPOPROTEIN E CONDITIONAL DISEASES
IS4957A (is) Hreinsuð prótein, samskeyttar DNA raðir og aðferðir til að stýra þroskun kaffiplantna
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
NO973193D0 (no) Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer
DE69717846D1 (de) Behandlungsverfahren von laktamen
NO963366D0 (no) Peptider og fremgangsmåte for behandling av diabetes
HUP9901204A3 (en) Novel protein hmw human mp52
NO980375D0 (no) Humant MP52 Arg protein
NO982562D0 (no) Sammensetning for behandling av smerte
NO960766D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
EP0780472A3 (en) Stress proteins
DE69614620D1 (de) Methoden zum Nachweis von menslichem Parvovirus
DE69420044D1 (de) Blutregulierende peptide

Legal Events

Date Code Title Description
MK1K Patent expired